In addition to drug combination therapy, WT p53 drug resistance, complex changes within tumor cells after drug administration to cope with off-target effects and toxicity, and interspecies variability between animals and humans leading to the need for in vitro models to verify drug efficacy are all issues that need attention in future research. Here, TP53 is linked to neoplasm.